瞬时弹性成像在肝纤维化无创诊断中的应用进展

罗文萍; 马红; 王宇

doi:10.3969/j.issn.1001-5256.2019.03.041

瞬时弹性成像在肝纤维化无创诊断中的应用进展

DOI: 10.3969/j.issn.1001-5256.2019.03.041

首都医科大学附属北京友谊医院肝病中心

基金项目:

国家科技重大专项(2017ZX10202202)；

详细信息

中图分类号: R575.2
计量
- 文章访问数: 1397
- HTML全文浏览量: 27
- PDF下载量: 411
- 被引次数: 0
出版历程
- 收稿日期: 2018-10-08
- 出版日期: 2019-03-20

Advances in the application of transient elastography in noninvasive diagnosis of liver fibrosis

Liver Research Center, Beijing Friendship Hospital, Capital Medical University

Research funding:

摘要

摘要: 肝活组织检查是肝纤维化诊断和分期的最敏感和特异的方法,但因其有创性及局限性,近年来肝纤维化无创评估方法在临床上得到广泛应用。其中瞬时弹性成像技术(TE)在病毒性肝炎、非酒精性脂肪性肝病、酒精性肝病、自身免疫性肝病等各种病因慢性肝病中的诊断效能已得到广泛验证,其对肝纤维化,尤其是肝硬化的诊断效能较好,已逐渐被写入一些国家临床指南。然而,TE对肝纤维化的诊断效能受相关因素,如转氨酶、胆红素、肝脏炎症、脂肪变性等影响。应结合具体的病因,联合多种无创方法,最大程度的提高诊断准确度。
- 弹性成像技术 /
- 肝硬化 /
- 诊断 /
- 综述
Abstract: Liver biopsy is the most sensitive and specific method for the diagnosis and staging of liver fibrosis, but its invasiveness and limi-tations have promoted the wide application of noninvasive evaluation methods for liver fibrosis in clinical practice in recent years. Variousstudies have proved the diagnostic efficiency of transient elastography ( TE) in chronic liver diseases of various etiologies, such as viral hepa-titis, nonalcoholic fatty liver disease, alcoholic liver disease, and autoimmune liver disease, especially in liver fibrosis and liver cirrhosis, and therefore, it has been incorporated into clinical practice guidelines in many countries. However, the diagnostic efficiency of TE in liverfibrosis is affected by several factors including aminotransferases, bilirubin, liver inflammation, and steatosis. Several noninvasive methodsshould be used in combination based on etiology to improve diagnostic accuracy.
- elasticity imaging techniques /
- liver cirrhosis /
- diagnosis /
- review

HTML全文

参考文献(35)

[1] ARENA U, VIZZUTTI F, ABRALDERS JG, et al. Reliability oftransient elastography for the diagnosis of advanced fibrosis inchronic hepatitis C[J]. Gut, 2008, 57 (9) :1288-1293.

[2] LIM JK, FLAMM SL, SINGH S, et al. American gastroenter-ological association institute guideline on the role of elastogra-phy in the evaluation of liver fibrosis[J]. Gastroenterology, 2017, 152 (6) :1536-1543.

[3] ZARSKI JP, STURM N, GUECHOT J, et al. Comparison of nineblood tests and transient elastography for liver fibrosis in chronichepatitis C:The ANRS HCEP-23 study[J]. J Hepatol, 2012, 56 (1) :55-62.

[4] HERRMANN E, de LDINGHEN V, CASSINOTTO C, et al. As-sessment of biopsy-proven liver fibrosis by two-dimensionalshear wave elastography:An individual patient data-based meta-analysis[J]. Hepatology, 2018, 67 (1) :260-272.

[5] RIZZO L, CALVARUSO V, CACOPARDO B, et al. Compari-son of transient elastography and acoustic radiation force im-pulse for non-invasive staging of liver fibrosis in patients withchronic hepatitis C[J]. Am J Gastroenterol, 2011, 106 (12) :2112-2120.

[6] Review Panel For Liver Stiffness Measurement. Recommenda-tions for the clinical application of transient elastography in liverfibrosis assessment[J]. Chin J Hepatol, 2013, 21 (6) :420-424. (in Chinese) 肝脏硬度评估小组.瞬时弹性成像技术诊断肝纤维化专家意见[J].中华肝脏病杂志, 2013, 21 (6) :420-424.

[7] QI XL, AN M, WU TW, et al. Transient elastography for signifi-cant liver fibrosis and cirrhosis in chronic hepatitis B:A meta-analysis[J]. Can J Gastroenterol Hepatol, 2018, 2018:3406789.

[8] European Association for Study of Liver, Asociacion Latino-americana para el Estudio del Higado. EASL-ALEH ClinicalPractice Guidelines:Non-invasive tests for evaluation of liverdisease severity and prognosis[J]. J Hepatol, 2015, 63 (1) :237-264.

[9] JIA JD, HOU JL, DING HG, et al. Transient elastographycompared to serum markers to predict liver fibrosis in a cohortof Chinese patients with chronic hepatitis B[J]. J Gastroen-terol Hepatol, 2015, 30 (4) :756-762.

[10] OOI GJ, MGAIETH S, ESLICK GD, et al. Systematic reviewand meta-analysis:Non-invasive detection of non-alcohol-ic fatty liver disease related fibrosis in the obese[J]. ObesRev, 2018, 19 (2) :281-294.

[11] IMAJO K, KESSOKU T, HONDA Y, et al. Magnetic resonanceimaging more accurately classifies steatosis and fibrosis in pa-tients with nonalcoholic fatty liver disease than transient elas-tography[J]. Gastroenterology, 2016, 150 (3) :626-637.

[12] PARK CC, NGUYEN P, HERNANDEZ C, et al. Magnetic reso-nance elastography vs transient elastography in detection of fi-brosis and noninvasive measurement of steatosis in patientswith biopsy-proven nonalcoholic fatty liver disease[J]. Gas-troenterology, 2017, 152 (3) :598-607.

[13] TAPPER EB, CHALLIES T, NASSER I, et al. The performanceof vibration controlled transient elastography in a US cohort ofpatients with nonalcoholic fatty liver disease[J]. Am J Gastro-enterol, 2016, 111 (5) :677-684.

[14] PAVLOV CS, CASAZZA G, NIKOLOVA D, et al. Systematic re-view with meta-analysis:Diagnostic accuracy of transient elas-tography for staging of fibrosis in people with alcoholic liver dis-ease[J]. Aliment Pharmacol Ther, 2016, 43 (5) :575-585.

[15] THIELE M, DETLEFSEN S, SEVELSTED MOLLER L, et al.Transient and 2-dimensional shear-wave elastography pro-vide comparable assessment of alcoholic liver fibrosis and cir-rhosis[J]. Gastroenterology, 2016, 150 (1) :123-133.

[16] THIELE M, MADSEN BS, HANSEN JF, et al. Accuracy of theenhanced liver fibrosis test vs fibrotest, elastography, and in-direct markers in detection of advanced fibrosis in patients withalcoholic liver disease[J]. Gastroenterology, 2018, 154 (5) :1369-1379.

[17] CORPECHOT C, CARRAT F, POUJOL-ROBERT A, et al.Noninvasive elastography-based assessment of liver fibrosisprogression and prognosis in primary biliary cirrhosis[J].Hepatology, 2012, 56 (1) :198-208.

[18] FRIEDRICH-RUST M, MULLER C, WINCKLER A, et al. As-sessment of liver fibrosis and steatosis in PBC with FibroScan, MRI, MR-spectroscopy, and serum markers[J]. J Clin Gas-troenterol, 2010, 44 (1) :58-65.

[19] CORPECHOT C, GAOUAR F, EL NAGGAR A, et al. Baselinevalues and changes in liver stiffness measured by transientelastography are associated with severity of fibrosis and out-comes of patients with primary sclerosing cholangitis[J]. Gas-troenterology, 2014, 146 (4) :970-979.

[20] HARTL J, DENZER U, EHLKEN H, et al. Transient elastogra-phy in autoimmune hepatitis:Timing determines the impact ofinflammation and fibrosis[J]. J Hepatol, 2016, 65 (4) :769-775.

[21] HARTL J, EHLKEN H, SEBODE M, et al. Usefulness of bio-chemical remission and transient elastography in monitoringdisease course in autoimmune hepatitis[J]. J Hepatol, 2017.[Epub ahead of print]

[22] XU FM, SHENG QS. Research advances in serum markersand transient elastography in the evaluation of liver fibrosis[J]. J Clin Hepatol, 2018, 34 (3) :618-622. (in Chinese) 许峰铭, 盛庆寿.血清标志物与瞬时弹性成像技术评估肝纤维化的研究进展[J].临床肝胆病杂志, 2018, 34 (3) :618-622.

[23] ARENA U, LUPSOR PLATON M, STASI C, et al. Liver stiff-ness is influenced by a standardized meal in patients withchronic hepatitis C virus at different stages of fibrotic evolution[J]. Hepatology, 2013, 58 (1) :65-72.

[24] DAS K, SARKAR R, AHMED SM, et al."Normal"liver stiff-ness measure (LSM) values are higher in both lean andobese individuals:A population-based study from a develo-ping country[J]. Hepatology, 2012, 55 (2) :584-593.

[25] WONG GL, WONG VW, CHIM AM, et al. Factors associatedwith unreliable liver stiffness measurement and its failure withtransient elastography in the Chinese population[J]. J Gastro-enterol Hepatol, 2011, 26 (2) :300-305.

[26] PETTA S, WONG VW, CAMMA C, et al. Improved noninva-sive prediction of liver fibrosis by liver stiffness measurement inpatients with nonalcoholic fatty liver disease accounting forcontrolled attenuation parameter values[J]. Hepatology, 2017, 65 (4) :1145-1155.

[27] TAPPER EB, COHEN EB, PATEL K, et al. Levels of alanineaminotransferase confound use of transient elastography to di-agnose fibrosis in patients with chronic hepatitis C virus infec-tion[J]. Clin Gastroenterol Hepatol, 2012, 10 (8) :932-937.

[28] MACALUSO FS, MAIDA M, CAMMA C, et al. Steatosis af-fects the performance of liver stiffness measurement for fibrosisassessment in patients with genotype 1 chronic hepatitis C[J]. J Hepatol, 2014, 61 (3) :523-529.

[29] FEIER D, LUPSOR PLATON M, STEFANESCU H, et al. Tran-sient elastography for the detection of hepatocellular carcino-ma in viral C liver cirrhosis. Is there something else than in-creased liver stiffness?[J]. J Gastrointestin Liver Dis, 2013, 22 (3) :283-289.

[30] HUANG R, GAO ZH, TANG A, et al. Transient elastographyis an unreliable marker of liver fibrosis in patients with portalvein thrombosis[J]. Hepatology, 2018, 68 (2) :783-785.

[31] MILAZZO L, PERI AM, LODI L, et al. Intestinal lymphangiec-tasia and reversible high liver stiffness[J]. Hepatology, 2014, 60 (2) :759-761.

[32] LEI JW, TAN BB, LI WB, et al. Value of transient elastographymeasured with Fibro Touch in the diagnosis of liver fibrosis inchronic hepatitis patients with hepatocellular carcinoma[J].Clin J Med Offic, 2017, 45 (9) :930-933. (in Chinese) 雷洁雯, 谭碧波, 李万斌, 等. Fibro Touch瞬时弹性成像诊断慢性乙型肝炎合并肝癌患者肝纤维化程度应用研究[J].临床军医杂志, 2017, 45 (9) :930-933.

[33] DUAN WJ, WANG XM, WANG Y, et al. Comparison of Fibro-Touch and FibroScan for the assessment of fibrosis in chronichepatitis B patients[J]. Chin J Exp Clin Virol, 2018, 32 (4) :399-402. (in Chinese) 段维佳, 王晓明, 王宇, 等. FibroTouch和FibroScan检测评估慢性乙型肝炎患者肝纤维化程度的诊断价值[J].中华实验和临床病毒学杂志, 2018, 32 (4) :399-402.

[34] ZHUANG XF, MA Y, WANG XZ, et al. The predictive valuesof three noninvasive indices in diagnosis of liver fibrosis in pa-tients with chronic hepatitis B:A comparative study[J]. J ClinHepatol, 2016, 32 (8) :1508-1512. (in Chinese) 庄小芳, 马燕, 王晓忠, 等. 3种无创诊断技术对慢性乙型肝炎肝纤维化的评估价值比较[J].临床肝胆病杂志, 2016, 32 (8) :1508-1512.

[35] ZHANG YG, ZHAO SX, ZHOU GD, et al. Correlation of Fibro-Touch and FibroScan with the stage of primary biliary cirrhosis[J]. Chin J Hepatol, 2016, 24 (12) :902-906. (in Chinese) 张玉果, 赵素贤, 周光德, 等. FibroTouch、FibroScan与原发性胆汁性肝硬化分期的相关性分析[J].中华肝脏病杂志, 2016, 24 (12) :902-906.

施引文献

资源附件(0)

访问统计